Doctors Note Logo

Published on: 9/26/2026

Which peptides are sold for building muscle, and do they work?

Peptides commonly sold for muscle growth include growth hormone secretagogues such as CJC-1295, ipamorelin, sermorelin, tesamorelin, GHRP-2, GHRP-6 and hexarelin, along with IGF-1 LR3, mechano growth factor, follistatin, and recovery-marketed compounds like BPC-157 and TB-500. While some of these do raise growth hormone or IGF-1 levels in the body, human evidence that they meaningfully increase muscle size or strength in healthy adults is weak, and most are sold as unapproved "research only" products with no guarantee of purity or dosing accuracy. Reported risks include water retention, joint pain, numbness, elevated blood sugar and insulin resistance, and unclear long-term effects, and nearly all are banned in tested sport. There are several important factors to weigh before using them, including drug interactions, underlying health conditions, and symptoms that may signal harm. See below for the full details you should consider.

If you are noticing symptoms like swelling, tingling, unusual fatigue, rapid weight changes, persistent joint pain, or blood sugar changes while using or considering these products, it is worth getting clarity quickly rather than guessing. A free, instant, online symptom check asks targeted questions about what you are experiencing, helps you understand possible causes, and points you toward the right level of care and the questions to raise with a clinician. It takes only a few minutes, requires no appointment, and can help you separate harmless side effects from warning signs that need prompt attention.

Last reviewed for medical accuracy: 09/26/2026

answer background

Explanation

Which Peptides Are Sold for Building Muscle, and Do They Work?

Interest in muscle building peptides has grown as athletes, bodybuilders and fitness enthusiasts seek alternatives to traditional steroids and supplements. Peptides are short chains of amino acids that can influence hormone release, tissue repair or muscle growth. Below is an evidence-based overview of the most common “muscle building peptides,” how they work, what research shows, and key safety considerations.


Common Muscle Building Peptides

  1. Growth Hormone Releasing Peptides (GHRPs)

    • GHRP-6
      • Stimulates growth hormone (GH) release by acting on ghrelin receptors.
      • May increase appetite (the “ghrelin effect”).
    • GHRP-2
      • Similar to GHRP-6 but with less impact on appetite.
    • Ipamorelin
      • Highly selective GH secretagogue with minimal effects on hunger or cortisol.
  2. Growth Hormone Releasing Hormone (GHRH) Analogs

    • CJC-1295 (with or without DAC)
      • Stimulates endogenous GH release via the pituitary.
      • DAC version extends peptide half-life, allowing fewer injections.
  3. Insulin-Like Growth Factor-1 (IGF-1) Variants

    • IGF-1 LR3
      • Longer-acting form of IGF-1.
      • Promotes muscle fiber growth by activating satellite cells in muscle tissue.
  4. Follistatin-344

    • Binds and inhibits myostatin, a protein that limits muscle growth.
    • Preclinical studies (rodents) show significant muscle hypertrophy.
  5. Thymosin Beta-4 (TB-500) & BPC-157

    • Primarily studied for tissue repair, inflammation reduction and tendon healing.
    • Indirectly support muscle recovery and may allow more intense training.

How These Peptides Work

  • Stimulating Growth Hormone (GH):
    GHRPs and GHRH analogs prompt the pituitary gland to release GH, which in turn boosts IGF-1 production in the liver and muscle. GH and IGF-1 drive protein synthesis, muscle cell proliferation and fat metabolism.

  • Inhibiting Myostatin:
    Follistatin-344 binds to myostatin and blocks its activity. Since myostatin naturally restrains muscle growth, blocking it can theoretically lead to rapid hypertrophy.

  • Enhancing Tissue Repair:
    TB-500 and BPC-157 upregulate angiogenesis (new blood vessel formation) and collagen production, speeding recovery from micro-tears and supporting overall muscle health.


What the Research Shows

  1. GHRP-6, GHRP-2 and CJC-1295

    • Small human trials (Journal of Clinical Endocrinology & Metabolism, 2007) report increased GH pulses and mild lean-mass gains.
    • Effects on performance and true muscle hypertrophy remain modest compared to pharmaceutical GH.
  2. Ipamorelin

    • Early studies (PubMed ID: 14580816) show reliable GH release without significant cortisol or prolactin increase.
    • Long-term muscle mass data in healthy adults are limited.
  3. IGF-1 LR3

    • Animal studies demonstrate robust muscle fiber growth.
    • Human data are sparse; some case reports note improved recovery but lack controlled trials.
  4. Follistatin-344

    • Rodent models exhibit up to 50% increase in muscle mass over weeks.
    • Safety profile in humans is not well established; clinical trials are ongoing.
  5. TB-500 & BPC-157

    • Preclinical data support faster healing of muscle, tendon and ligament injuries.
    • Anecdotal reports attest to reduced downtime between workouts.

Overall, most evidence comes from small-scale or animal studies. Robust, placebo-controlled human trials are lacking for many peptides marketed for muscle building.


Safety and Side Effects

  • Injection Site Reactions: Pain, redness or irritation.
  • Hormonal Imbalance: Overstimulation of GH axis can cause water retention, joint pain, insulin resistance or carpal tunnel syndrome.
  • Organ Stress: Chronic GH elevation may affect the heart, liver or kidneys.
  • Myostatin Inhibitors: Long-term effects of myostatin blockade are unknown; potential for uncontrolled cell growth.
  • Quality Concerns: Many peptides are sourced from compounding pharmacies or online vendors with variable purity and potency.

Before trying any peptide regimen, consider:

  • Verifying source credibility and batch testing certificates.
  • Monitoring blood glucose, lipid profile and hormone levels.
  • Starting with low doses under medical supervision.
  • Stopping immediately if you experience severe side effects.

Legal and Regulatory Status

  • In many countries, peptides like GHRPs, CJC-1295 and IGF-1 variants are not approved by regulatory bodies (e.g., FDA) for muscle building.
  • Using them off-label may carry legal risks and challenges getting medical insurance coverage.
  • Professional sports organizations ban most peptides under anti-doping rules.

Practical Takeaways

  • Muscle building peptides may offer an edge, but benefits are generally smaller and less predictable than advertised.
  • Research quality varies: strong preclinical results don’t always translate to real-world gains.
  • Safety and purity of product sources are major concerns.
  • Cost can be high, especially for sustained regimens with frequent injections.

If you’re experiencing unexplained symptoms—fatigue, swelling, joint pain or hormonal changes—you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.


Next Steps and Recommendations

  1. Speak to a doctor before starting any peptide, especially if you have:

    • Diabetes or insulin resistance
    • Cardiovascular disease
    • Hormonal disorders
    • Active cancer or a history of tumors
  2. Discuss potential drug interactions and baseline lab evaluations.

  3. Consider conventional, evidence-based approaches first:

    • Progressive resistance training
    • Adequate protein intake (1.6–2.2 g/kg/day)
    • Sufficient sleep (7–9 hours/night)
    • Caloric surplus for muscle gain

Conclusion

Muscle building peptides can stimulate growth hormone release, inhibit myostatin or speed tissue repair, but most human data are limited. Potential gains may be real but modest, and safety concerns are significant. Always verify the purity of any product, monitor your health closely and discuss risks and benefits with a qualified healthcare professional. If you experience serious or life-threatening symptoms, seek medical attention immediately.

Speak to a doctor about any treatment that could impact your health long term.

(References)

  • * Tipton KD, Wolfe RR. Exercise, protein metabolism, and muscle growth. Int J Sport Nutr Exerc Metab. 2001 Mar;11(1):109-32. doi: 10.1123/ijsnem.11.1.109. PMID: 11255140.

  • * Schoenfeld BJ. The mechanisms of muscle hypertrophy and their application to resistance training. J Strength Cond Res. 2010 Oct;24(10):2857-72. doi: 10.1519/JSC.0b013e3181e840f3. PMID: 20847704.

  • * Sharma M, McFarlane C, Kambadur R, Kukreti H, Bonala S, Srinivasan S. Myostatin: expanding horizons. IUBMB Life. 2015 Aug;67(8):589-600. doi: 10.1002/iub.1392. Epub 2015 Aug 25. PMID: 26305594.

  • * Farshidfar F, Pinder MA, Myrie SB. Creatine Supplementation and Skeletal Muscle Metabolism for Building Muscle Mass- Review of the Potential Mechanisms of Action. Curr Protein Pept Sci. 2017;18(12):1273-1287. doi: 10.2174/1389203718666170606105108. PMID: 28595527.

  • * Liu L, Liu X, Bai Y, Tang N, Li J, Zhang Y, Wu J, Wang X, Wei J. Neuregulin-1β modulates myogenesis in septic mouse serum-treated C2C12 myotubes in vitro through PPARγ/NF-κB signaling. Mol Biol Rep. 2018 Dec;45(6):1611-1619. doi: 10.1007/s11033-018-4293-6. Epub 2018 Sep 3. PMID: 30178217.

  • * Lee EJ, Shaikh S, Baig MH, Park SY, Lim JH, Ahmad SS, Ali S, Ahmad K, Choi I. MIF1 and MIF2 Myostatin Peptide Inhibitors as Potent Muscle Mass Regulators. Int J Mol Sci. 2022 Apr 11;23(8). doi: 10.3390/ijms23084222. Epub 2022 Apr 11. PMID: 35457038; PMCID: PMC9031736.

  • * Wu Y, Liu X, Fan Y, Zuo H, Niu X, Zuo B, Xu Z. MiR-34b Regulates Muscle Growth and Development by Targeting SYISL. Cells. 2025 Mar 5;14(5). doi: 10.3390/cells14050379. Epub 2025 Mar 5. PMID: 40072107; PMCID: PMC11898696.

  • * Männistö A, Tonttila K, Ortega-Alonso A, Nurmi H, Uusitalo-Kylmälä L, Amudhala Hemanthakumar K, Saikkala E, Myllykangas S, Vertainen S, Nissinen TA, Pasternack A, Ritvos O, Alitalo KK, Hulmi JJ, Kivelä R. Combined angiogenic and hypertrophic gene therapy enhances skeletal muscle growth. Am J Physiol Cell Physiol. 2025 Aug 1;329(2):C540-C559. doi: 10.1152/ajpcell.00966.2024. Epub 2025 Jul 7. PMID: 40622896.

  • * Zhang M, Liu S, Wang Y, Shan S, Cang M. HO-1 Suppression by Co-Culture-Derived IL-6 Alleviates Ferritinophagy-Dependent Oxidative Stress to Potentiate Myogenic Differentiation. Cells. 2025 Aug 10;14(16). doi: 10.3390/cells14161234. Epub 2025 Aug 10. PMID: 40862713; PMCID: PMC12384154.

  • * Liu X, Yao Y, Yan J, Zeng M, Fan X, Tang Y, Li J, Liu Y, Yan S, Wang W, Chen L, Chen R, Huang Y, Calnan H, Wang H, Gardner G, Yang Y, Tang Z. RPS27L Enhances Myogenesis and Muscle Mass by Targeting IGF1 Through Liquid-Liquid Phase Separation. Adv Sci (Weinh). 2025 Nov;12(44):e12354. doi: 10.1002/advs.202512354. Epub 2025 Aug 31. PMID: 40886325; PMCID: PMC12667544.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.